We are live on ! Find out more

Large Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MDLN icon
51
Medline Inc
MDLN
$28.2B
$28.2B $32.12 0.37%
DGX icon
52
Quest Diagnostics
DGX
$27.8B
$27.8B $251.82 0.43%
ROIV icon
53
Roivant Sciences
ROIV
$26.7B
$26.7B $36.91 1.63%
PHG icon
54
Philips
PHG
$26.3B
$26.3B $26.92 0.74%
UTHR icon
55
United Therapeutics
UTHR
$25.7B
$25.7B $598.72 0.87%
INSM icon
56
Insmed
INSM
$24.7B
$24.7B $112.58 0.89%
INCY icon
57
Incyte
INCY
$24.5B
$24.5B $120.39 3.07%
GH icon
58
Guardant Health
GH
$24B
$24B $178.80 3.51%
BNTX icon
59
BioNTech
BNTX
$22.1B
$22.1B $88.17 1.08%
STE icon
60
Steris
STE
$22.1B
$22.1B $227.12 2.16%
ALNY icon
61
Alnylam Pharmaceuticals
ALNY
$22.1B
$22.1B $165 5.17%
VTRS icon
62
Viatris
VTRS
$21.9B
$21.9B $19.04 0.83%
THC icon
63
Tenet Healthcare
THC
$21.7B
$21.7B $273.25 0.99%
VHT icon
64
Vanguard Health Care ETF
VHT
$20.7B
$20.7B $342.33 0.12%
MEDP icon
65
Medpace
MEDP
$18.2B
$18.2B $652.01 3.77%
ZBH icon
66
Zimmer Biomet
ZBH
$18B
$18B $94.52 3.03%
RVTY icon
67
Revvity
RVTY
$17.5B
$17.5B $157 5.3%
CRL icon
68
Charles River Laboratories
CRL
$17.2B
$17.2B $359.41 4.44%
EXEL icon
69
Exelixis
EXEL
$16.9B
$16.9B $69.39 4.82%
ASND icon
70
Ascendis Pharma A/S
ASND
$16.5B
$16.5B $251.27 0.68%
ICLR icon
71
Icon
ICLR
$15.8B
$15.8B $211.36 1.91%
HALO icon
72
Halozyme
HALO
$14.9B
$14.9B $130.91 0.21%
NBIX icon
73
Neurocrine Biosciences
NBIX
$14.9B
$14.9B $146.10 0.19%
BBIO icon
74
BridgeBio Pharma
BBIO
$14.6B
$14.6B $74.95 5.97%
GKOS icon
75
Glaukos
GKOS
$14.1B
$14.1B $237.60 2.01%
1 2
3
4 5

Large Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 104 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.5T.

The largest by market cap are Abbott (ABT) at $184B, Novo Nordisk (NVO) at $176B and Pfizer (PFE) at $174B.

Among institutional investors, CVS Health (CVS) drew the most net new fund positions in Q2 2026: 326 funds opened new positions, taking total fund holders up 198 (10%) quarter-over-quarter.

  • Combined market cap: $4.5T across 104 stocks.
  • Large Cap: market cap between $10B and $200B.
  • Largest constituent: Abbott (ABT), $184B market cap.
  • Most net new fund positions in Q2 2026: CVS Health (CVS), +198 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.